Cantareira: calou e amarelou. A experiência de Mairiporã na gestão da Febre Amarela
Bertolini, Grazielle Cristina dos Santos; Kemp, Brigina.
BIS, Bol. Inst. Saúde (Impr.)
; 19(supl): 16-19, 2018.
Artigo em Português | LILACS, SES-SP, SESSP-ISPROD, SES-SP, SESSP-ISACERVO | ID: biblio-1009357
Documentos relacionados
Duration of Protection After Vaccination Against Yellow Fever: A Systematic Review and Meta-Analysis.
Yellow Fever Vaccine-Associated Viscerotropic Disease among Siblings, São Paulo State, Brazil.
Performance assessment and validation of a plaque reduction neutralization test (PRNT) in support to yellow fever diagnostic and vaccine clinical trials.
Yellow Fever as Cause of Death of Titi Monkeys (<i>Callicebus</i> Spp.).
Yellow Fever.
Modelling epidemics with fractional-dose vaccination in response to limited vaccine supply.
The resurgence of yellow fever outbreaks in Nigeria: a 2-year review 2017-2019.
Guiding Yellow Fever Vaccination Strategy Worldwide: Booster = Better?
Serum soluble mediators as prognostic biomarkers for morbidity, disease outcome, and late-relapsing hepatitis in yellow fever patients.
Th22 cytokines and yellow fever: Possible implications for the immunopathogenesis of human liver infection.